paltusotine

Generic: paltusotine·Brand: PALSONIFY

paltusotine: developed by 1 company · 2 FDA decisions. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
Crinetics Pharmaceuticals, Inc. (CRNX)Phase 2

FDA Decisions

PDUFAacromegaly(CRNX)
FDA_MeetingNew Drug Application submitted to the FDA for paltusotine for treatment and long-term maintenance therapy of acromegaly.(CRNX)

Frequently asked questions

Who is developing paltusotine?

paltusotine is being developed by Crinetics Pharmaceuticals, Inc..

What is paltusotine's latest FDA decision?

The most recent tracked FDA decision for paltusotine is PDUFA for acromegaly, dated September 25, 2025.

Get deeper analysis on paltusotine

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    paltusotine — Drug Pipeline, Trials & FDA Status | BioSniper